Research, brought to the Community
We give our patients access to clinical research through access to advanced imaging technologies that we believe may improve survival and quality of life, without leaving the communities where they live.
Research is critically important and vital to our mission. RadNet’s scale, technology platform, and patient population allow promising innovations to be rigorously tested, validated, and translated into tools that can improve care for millions of patients worldwide. This is fundamental to who we are as a company.
Norman R. Hames · President and CEO, RadNet Western Operations
Two arms of research
In cancer research, RadNet supports oncology trials through our partnerships with not-for-profit entities and community and academic oncology partners, reaching patients in their own communities.
In imaging research, RadNet partners with international pharmaceutical and biotechnology companies on imaging trials.
RadNet’s research roots run through Breastlink, whose research group has run community-based trials since 1995. RadNet acquired Breastlink in 2008 and built its research program from there.
What began as a four-person department focused primarily on supporting breast oncology clinical trials in California has grown into a team that manages a wide range of imaging research projects, from clinical trials and imaging vendor studies to collaborations with leading medical technology companies and academic medical centers.
Three examples
Participating in research lets RadNet gain experience with emerging technologies and therapies often years before they become commercially available.
Fatty liver disease
RadNet has also been very involved in clinical trials for fatty liver disease (known by the acronyms MASH and MASLD). When RadNet started participating in these clinical trials, there were no drugs available to treat this disease.
Alzheimer’s imaging
RadNet participated in early clinical trials evaluating amyloid PET tracers before they received FDA approval. As a result, contracted radiologists gained valuable experience interpreting these technologies long before they entered routine clinical practice.
Breast cancer
Breast oncology trials are where RadNet’s research began, and the team participates in clinical trials to improve prevention, screening and diagnosis.
RadNet focuses on supporting referring physicians and organizations conducting research that needs high-quality imaging.
Who leads it
Kristi Maya
Senior Vice President, Clinical Research
Judith Rose, M.D.
Director, PET/CT and Nuclear Medicine
Research inquiries
For more information on our research initiatives, contact the Study Start-Up Team.